Hudson out at Sanofi, as Belén Garijo named CEO
The board at Sanofi has said it will not renew CEO Paul Hudson's contract, and has turned to former Merck CEO Belén Garijo to lead the group.
Newsletters and Deep Dive digital magazine
The board at Sanofi has said it will not renew CEO Paul Hudson's contract, and has turned to former Merck CEO Belén Garijo to lead the group.
Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.
Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
Already sitting on a blockbuster therapy for MASH, Madrigal has beefed up its pipeline with six siRNA candidates licensed from China's Ribo.
The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.
Editor's Picks
Newsletters and Deep Dive
digital magazine